Luspatercept for transfusion-dependent β-thalassemia: time to get real

Eitemau Tebyg

• Luspatercept for transfusion-dependent β-thalassemia: time to get real
  gan: Khaled M. Musallam, et al.
  Cyhoeddwyd: (2023-08-01)
• Profile of Luspatercept in the Treatment of Anemia in Adults with Non-Transfusion-Dependent β-Thalassemia (NTDT): Design, Development and Potential Place in Therapy
  gan: Musallam KM, et al.
  Cyhoeddwyd: (2023-05-01)
• Efficacy and safety of luspatercept in non–transfusion-dependent β-thalassemia: long-term results from the BEYOND study
  gan: Ali T. Taher, et al.
  Cyhoeddwyd: (2025-12-01)
• ENERGIZE: A GLOBAL PHASE 3 STUDY OF MITAPIVAT DEMONSTRATING EFFICACY AND SAFETY IN ADULTS WITH ALPHA- OR BETA-NON–TRANSFUSION-DEPENDENT THALASSEMIA
  gan: AT Taher, et al.
  Cyhoeddwyd: (2024-10-01)
• IMPROVEMENTS IN FATIGUE AND 6-MINUTE WALK TEST IN ADULTS WITH ALPHA- OR BETA-NON–TRANSFUSION-DEPENDENT THALASSEMIA: THE PHASE 3 ENERGIZE TRIAL OF MITAPIVAT
  gan: KH Kuo, et al.
  Cyhoeddwyd: (2024-10-01)